^
    CANCER:

    Endometrial Adenocarcinoma





    Show legend
    Group by Gene:
    Include preclinical:

    0
    HER2 inhibitor
    trastuzumab
    1
    WEE1 inhibitor
    ZN-c3
    AZD1775
    2
    PD1 inhibitor
    nivolumab
    pembrolizumab
    3
    CDK4 inhibitor, CDK6 inhibitor
    abemaciclib
    4
    Aromatase inhibitor
    letrozole
    5
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    afatinib
    6
    Immunotherapy
    Immunotherapy
    7
    HER2 inhibitor, EGFR inhibitor
    lapatinib
    trastuzumab + lapatinib
    No biomarker
    HER-2 expression
    HER-2 overexpression
    HER-2 positive
    HER-2 amplification
    ER positive
    MSI-H/dMMR
    MSH2 deletion
    MLH1 deletion
    MSH6 F1088fs
    ARID1A mutation